Drug
deuruxolitinib phosphate
Marketed as LEQSELVI.
Generic name
deuruxolitinib phosphate
Brand names
LEQSELVI
First FDA approval
2024-07-25
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA217900 | LEQSELVI | 2024-07-25 | SUN PHARM INDS INC |
Manufacturers
SUN PHARM INDS INC
Frequently asked questions
When was deuruxolitinib phosphate FDA approved?
Earliest FDA approval on record: 2024-07-25.
What brand names are sold as deuruxolitinib phosphate?
LEQSELVI.
Sources
Appeal a deuruxolitinib phosphate denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com